Skip to main content

Peer Review reports

From: Comparing stereotactic ablative radiotherapy (SABR) versus re-trans-catheter arterial chemoembolization (re-TACE) for hepatocellular carcinoma patients who had incomplete response after initial TACE (TASABR): a randomized controlled trial

Original Submission
3 Sep 2017 Submitted Original manuscript
3 Oct 2017 Author responded Author comments - Liang-Cheng Chen
Resubmission - Version 2
3 Oct 2017 Submitted Manuscript version 2
25 Apr 2018 Author responded Author comments - Liang-Cheng Chen
Resubmission - Version 3
25 Apr 2018 Submitted Manuscript version 3
28 Oct 2018 Reviewed Reviewer Report - Nicholas Fidelman
8 Nov 2018 Reviewed Reviewer Report - Daniel R. Ganger
9 Jan 2019 Author responded Author comments - Liang-Cheng Chen
Resubmission - Version 4
9 Jan 2019 Submitted Manuscript version 4
29 Jan 2019 Author responded Author comments - Liang-Cheng Chen
Resubmission - Version 5
29 Jan 2019 Submitted Manuscript version 5
10 Feb 2019 Author responded Author comments - Liang-Cheng Chen
Resubmission - Version 6
10 Feb 2019 Submitted Manuscript version 6
Publishing
12 Mar 2019 Editorially accepted
28 Mar 2019 Article published 10.1186/s12885-019-5461-3

You can find further information about peer review here.

Back to article page